Search research articles
Contact Us
Filters
Showing results (91-100 of 97) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 97 results.
Blood
|
October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group
E Wattel, A Guerci, B Hecquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2005
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
H P Kalofonos, G Aravantinos, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, P Papakostas, U Dafni, et al.
British Journal of Cancer
|
November 6, 2008
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study
A K Koutras, K T Kalogeras, M-A Dimopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study
H P Kalofonos, A Bamias, A Koutras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, H P Kalofonos, U Dafni, et al.
Anticancer Research
|
March 12, 1998
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study
G Fountzilas, S Vasilaros, D Koukouras, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 97) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 97 results.
Blood
|
October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group
E Wattel, A Guerci, B Hecquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2005
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
H P Kalofonos, G Aravantinos, P Kosmidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, P Papakostas, U Dafni, et al.
British Journal of Cancer
|
November 6, 2008
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study
A K Koutras, K T Kalogeras, M-A Dimopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study
H P Kalofonos, A Bamias, A Koutras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2004
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group
G Fountzilas, H P Kalofonos, U Dafni, et al.
Anticancer Research
|
March 12, 1998
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study
G Fountzilas, S Vasilaros, D Koukouras, et al.
Page
of 10